FI962021L - 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina - Google Patents

5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina Download PDF

Info

Publication number: FI962021L
Authority: FI; Finland
Prior art keywords: protease inhibitors; antiviral agents; dihydropyrone derivatives; dihydropyrone; derivatives
Prior art date: 1993-11-19

Application number

FI962021A

Other languages

English (en)

Swedish (sv)

Other versions

FI962021A7 (fi

FI962021A0 (fi

Inventor

Edmund L Ellsworth

Elizabeth Lunney

Bradley Dean Tait

Original Assignee

Parke Davis & Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-11-19

Filing date

1994-10-26

Publication date

1996-07-12

1994-10-12 Priority claimed from US08/319,821 external-priority patent/US5789440A/en

1994-10-26 Application filed by Parke Davis & Co filed Critical Parke Davis & Co

1996-05-13 Publication of FI962021A0 publication Critical patent/FI962021A0/fi

1996-07-12 Publication of FI962021A7 publication Critical patent/FI962021A7/fi

1996-07-12 Publication of FI962021L publication Critical patent/FI962021L/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
- C07C321/24—Thiols, sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
- C07C321/26—Thiols
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/96—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings spiro-condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Veterinary Medicine (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Oncology (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Pyrane Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

FI962021A 1993-11-19 1994-10-26 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina FI962021L (fi)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US15544393A	1993-11-19	1993-11-19
US08/319,821 US5789440A (en)	1993-11-19	1994-10-12	5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
PCT/US1994/012234 WO1995014011A2 (en)	1993-11-19	1994-10-26	5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents

Publications (3)

Publication Number	Publication Date
FI962021A0 FI962021A0 (fi)	1996-05-13
FI962021A7 FI962021A7 (fi)	1996-07-12
FI962021L true FI962021L (fi)	1996-07-12

Family

ID=26852339

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI962021A FI962021L (fi)	1993-11-19	1994-10-26	5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina

Country Status (27)

Country	Link
US (1)	US5936128A (fi)
EP (1)	EP0729463B1 (fi)
JP (1)	JP3698435B2 (fi)
AT (1)	ATE217871T1 (fi)
AU (1)	AU680064B2 (fi)
BG (1)	BG63012B1 (fi)
CA (1)	CA2176041A1 (fi)
CZ (1)	CZ291856B6 (fi)
DE (1)	DE69430671T2 (fi)
DK (1)	DK0729463T3 (fi)
EE (1)	EE9600045A (fi)
ES (1)	ES2176263T3 (fi)
FI (1)	FI962021L (fi)
HR (1)	HRP940936B1 (fi)
HU (1)	HUT75225A (fi)
IL (1)	IL111673A (fi)
MD (2)	MD1560G2 (fi)
NO (1)	NO315117B1 (fi)
NZ (1)	NZ275318A (fi)
PL (1)	PL180634B1 (fi)
PT (1)	PT729463E (fi)
RO (1)	RO117850B1 (fi)
RU (1)	RU2160733C2 (fi)
SI (1)	SI0729463T1 (fi)
SK (1)	SK283240B6 (fi)
TJ (1)	TJ320B (fi)
WO (1)	WO1995014011A2 (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997014812A2 (en) *	1995-10-16	1997-04-24	Chiron Corporation	Method of screening for factors that modulate gene expression
CA2235394A1 (en)	1995-11-13	1997-05-22	Gerard Voerman	Anti-viral isolates obtainable from leeches
US5834506A (en) *	1996-11-01	1998-11-10	Warner-Lambert Company	Dihydropyrones with improved antiviral activity
US6087455A (en) *	1997-12-19	2000-07-11	Shell Oil Company	Process for hydrogenation of macromolecular organic substrates
CA2339275A1 (en) *	1998-09-11	2000-03-23	Warner-Lambert Company	5,6-dihydro-4-hydroxy-2-pyranones as hiv aspartyl protease inhibitors
DE10030094A1 (de)	2000-06-19	2001-12-20	Bayer Ag	Phenylsubstituierte 5,6-Dihydro-pyron-Derivate
DE10100175A1 (de) *	2001-01-04	2002-07-11	Bayer Ag	Hetarylsubstituierte Homotetram-und Homotetronsäuren
DOP2003000641A (es)	2002-05-10	2003-11-15	Pfizer	Inhibidores de las arn polimerasa dependiente de arn del virus de las hepatitis c y composiciones y tratamiento que los usan
US7148226B2 (en)	2003-02-21	2006-12-12	Agouron Pharmaceuticals, Inc.	Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
UA88909C2 (ru)	2004-08-18	2009-12-10	Пфайзер Инк.	Ингибиторы рнк-зависимой рнк-полимеразы вируса гепатита с, фармацевтическая композиция на их основе и их применение
CN101225066B (zh) *	2007-01-18	2010-09-22	国鼎生物科技股份有限公司	牛樟芝的环己烯酮萃取物
WO2009126305A1 (en) *	2008-04-11	2009-10-15	The Trustees Of Columbia University	Glucose metabolism modulating compounds
EP3068416A4 (en)	2013-11-11	2017-08-09	Kuality Herbceutics LLC	Kava derived therapeutic compounds and methods of use thereof
CN108026084A (zh) *	2015-05-07	2018-05-11	夸利蒂赫布丘蒂克斯公司	治疗化合物及其使用方法
WO2017218617A1 (en) *	2016-06-14	2017-12-21	Bristol-Myers Squibb Company	4-hydroxy-3-sulfonylpyridin-2(1h)-ones as apj receptor agonists
MA46546A (fr)	2016-10-17	2021-05-05	Genentech Inc	Composés thérapeutiques et leurs procédés d'utilisation
GB201707856D0 (en)	2017-05-16	2017-06-28	Arctic Pharma As	Compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3206276A (en) *	1961-09-28	1965-09-14	Minerals Engineering Company	Process for recovery of pure v2o5 from vanadium bearing materials
US3206476A (en) *	1962-06-04	1965-09-14	Sterling Drug Inc	3-substituted-4-hydroxy-6-aryl-2-pyrones and preparation
US3931235A (en) *	1972-12-18	1976-01-06	The Dow Chemical Company	Process for preparing sulfur-containing hydroxy pyrones
US3818046A (en) *	1972-12-18	1974-06-18	Dow Chemical Co	Sulfur-containing hydroxy pyrones and alkali metal salts thereof
IL85347A0 (en) *	1987-02-11	1988-07-31	May & Baker Ltd	Cyclic diones
AU4074789A (en) *	1988-03-01	1989-09-22	Upjohn Company, The	Coumarins to inhibit reverse transcriptase in humans
JPH03227923A (ja) *	1990-01-30	1991-10-08	Sawai Seiyaku Kk	ひと免疫不全ウイルス疾患処置剤
CA2121363A1 (en) *	1991-11-18	1993-05-27	Mehrdad Badie	User selectable noise cancelling for portable microphones
ZA938019B (en) *	1992-11-13	1995-04-28	Upjohn Co	Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses
IL108459A0 (en) *	1993-02-05	1994-04-12	Opjohn Company	4-Hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl [B] pyran-2-ones useful for treating infections due to hiv and other retroviruses

1994
- 1994-10-26 NZ NZ275318A patent/NZ275318A/xx unknown
- 1994-10-26 SI SI9430417T patent/SI0729463T1/xx unknown
- 1994-10-26 RO RO96-01015A patent/RO117850B1/ro unknown
- 1994-10-26 SK SK646-96A patent/SK283240B6/sk unknown
- 1994-10-26 EP EP94932030A patent/EP0729463B1/en not_active Expired - Lifetime
- 1994-10-26 RU RU96113141/04A patent/RU2160733C2/ru not_active IP Right Cessation
- 1994-10-26 MD MD96-0172A patent/MD1560G2/ro not_active IP Right Cessation
- 1994-10-26 CA CA002176041A patent/CA2176041A1/en not_active Abandoned
- 1994-10-26 HU HU9601349A patent/HUT75225A/hu not_active Application Discontinuation
- 1994-10-26 ES ES94932030T patent/ES2176263T3/es not_active Expired - Lifetime
- 1994-10-26 AU AU80900/94A patent/AU680064B2/en not_active Ceased
- 1994-10-26 PT PT94932030T patent/PT729463E/pt unknown
- 1994-10-26 DK DK94932030T patent/DK0729463T3/da active
- 1994-10-26 EE EE9600045A patent/EE9600045A/xx unknown
- 1994-10-26 FI FI962021A patent/FI962021L/fi unknown
- 1994-10-26 JP JP51445495A patent/JP3698435B2/ja not_active Expired - Fee Related
- 1994-10-26 DE DE69430671T patent/DE69430671T2/de not_active Expired - Fee Related
- 1994-10-26 TJ TJ96000290A patent/TJ320B/xx unknown
- 1994-10-26 PL PL94314483A patent/PL180634B1/pl not_active IP Right Cessation
- 1994-10-26 WO PCT/US1994/012234 patent/WO1995014011A2/en not_active Ceased
- 1994-10-26 AT AT94932030T patent/ATE217871T1/de not_active IP Right Cessation
- 1994-10-26 CZ CZ19961368A patent/CZ291856B6/cs not_active IP Right Cessation
- 1994-10-26 MD MD96-0172D patent/MD1560F2/xx not_active IP Right Cessation
- 1994-11-17 HR HR940936A patent/HRP940936B1/xx not_active IP Right Cessation
- 1994-11-17 IL IL11167394A patent/IL111673A/xx not_active IP Right Cessation
1996
- 1996-05-03 BG BG100563A patent/BG63012B1/bg unknown
- 1996-05-15 NO NO19962018A patent/NO315117B1/no not_active IP Right Cessation
1998
- 1998-05-15 US US09/079,689 patent/US5936128A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
FI962021A7 (fi)	1996-07-12
US5936128A (en)	1999-08-10
EP0729463A1 (en)	1996-09-04
BG63012B1 (bg)	2001-01-31
HUT75225A (en)	1997-04-28
MD960172A (en)	1999-01-31
RO117850B1 (ro)	2002-08-30
DE69430671T2 (de)	2002-11-21
PT729463E (pt)	2002-10-31
IL111673A (en)	1999-04-11
RU2160733C2 (ru)	2000-12-20
NO315117B1 (no)	2003-07-14
MD1560F2 (en)	2000-11-30
PL314483A1 (en)	1996-09-16
DE69430671D1 (de)	2002-06-27
CZ291856B6 (cs)	2003-06-18
AU680064B2 (en)	1997-07-17
SI0729463T1 (en)	2002-08-31
JP3698435B2 (ja)	2005-09-21
NZ275318A (en)	1999-06-29
NO962018D0 (no)	1996-05-15
WO1995014011A3 (en)	1995-06-29
IL111673A0 (en)	1995-01-24
FI962021A0 (fi)	1996-05-13
ES2176263T3 (es)	2002-12-01
JPH09505292A (ja)	1997-05-27
EP0729463B1 (en)	2002-05-22
DK0729463T3 (da)	2002-09-09
EE9600045A (et)	1996-10-15
AU8090094A (en)	1995-06-06
HU9601349D0 (en)	1996-07-29
BG100563A (bg)	1996-12-31
HRP940936B1 (en)	2003-12-31
SK64696A3 (en)	1997-03-05
CA2176041A1 (en)	1995-05-26
WO1995014011A2 (en)	1995-05-26
MD1560G2 (ro)	2001-07-31
TJ320B (en)	2001-10-22
CZ136896A3 (en)	1997-12-17
NO962018L (no)	1996-07-04
PL180634B1 (pl)	2001-03-30
ATE217871T1 (de)	2002-06-15
HRP940936A2 (en)	1997-08-31
SK283240B6 (sk)	2003-04-01

Publication	Publication Date	Title
FI962022L (fi)	1996-07-12	5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina
ATE286025T1 (de)	2005-01-15	Hiv protease inhibitoren
NO942064D0 (no)	1994-06-03	yminhibitorer
FI943976A7 (fi)	1995-03-01	5-aryyli-indolijohdannaiset
FI955316A7 (fi)	1995-12-22	Vitamiini D:n amidijohdannaisia
FI962021L (fi)	1996-07-12	5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina
FI962488A7 (fi)	1996-06-14	HIV:n proteaasin inhibiittoreita
FI945674L (fi)	1995-06-03	Substituoidut 2beta-morfoliini-androstaanijohdannaiset
ZA949148B (en)	1995-07-21	5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
FI942444A7 (fi)	1994-11-28	Terahydropyraanijohdannaisia
ZA949150B (en)	1995-07-31	Pyrone derivatives as protease inhibitors and antiviral agents.
FI943885L (fi)	1995-02-25	Penaami-johdannaiset
NO950477D0 (no)	1995-02-09	Aminosyrederivater
FI944044L (fi)	1995-03-03	Fenyylialkanoliamiinijohdannaiset
FI941149L (fi)	1994-12-22	2,4-diamino-3-hydroksikarboksyylihapon johdannaisia
FI962019L (fi)	1996-05-20	Pyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina
FI962020L (fi)	1996-05-31	Pyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina
DE59407726D1 (de)	1999-03-11	3-Aryl-4-hydroxy-3-dihydrofuranon-Derivate
FI956045L (fi)	1995-12-15	Antiparasiittisina aineina käyttökelpoiset 14-substituoidut markfortiinit ja johdannaiset
NO950327D0 (no)	1995-01-27	Pyridoindolobenzodiazepiner og derivater som antipsykotiske midler
DE69400388D1 (de)	1996-09-26	Cyclohexendiolderivate
KR930021222U (ko)	1993-10-15	스패너
SI0729465T1 (en)	2003-06-30	Pyrone derivatives as protease inhibitors and antiviral agents
NO934473D0 (no)	1993-12-08	N-substituerte azabicykloheptanderivater
FI933459A0 (fi)	1993-08-04	Vaermevaexlare i kombination med varmvatten- och aongberedarpanna